China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of factors influencing the prognosis of primary and secondary IgA nephropathy and the establishment of a prognosis prediction model'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133964
Registration Time: 2026/10/09
Type: Observational study
Primary Sponsor: Huashan Hospital, Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342969
Published by HT Digital Content Services with permission from Health Daily Digest....